A real-world example
I will include at least one real-world example to illustrate my point.
Pharma Summit USA speakers
Request your invitation
Dr. Elena Vasquez
Chief Medical Officer
Elena oversees clinical strategy across Moderna's infectious disease and oncology pipelines.
Dr. Anita Rao
Chief Medical Officer
Leads global medical strategy, translating clinical evidence into patient-centred launch and access decisions.
Marcus Chen
VP Regulatory Affairs
Marcus leads global regulatory strategy for Pfizer's emerging markets portfolio.
Dr. Rachel Kim
Head of Digital Health
Rachel builds digital therapeutics and remote monitoring programmes at Johnson & Johnson.
James Whitfield
VP, Regulatory Affairs
Runs global regulatory strategy across oncology and respiratory, with a focus on accelerated approval pathways.
Dr. Sofia Bergman
Head of Clinical Data Science
Builds the data and AI foundations behind faster, more representative clinical trials.
David Osei
Director, Patient Access
Designs affordability and access programmes that get therapies to the patients who need them.
Dr. Priyanka Menon
SVP, R&D
Oversees a pipeline spanning immunology and rare disease, championing translational science.
Andreas Beck
Head of Clinical Data Science
Andreas builds the data platforms behind Bayer’s decentralised trial programmes.
Dr. Peter Lindqvist
SVP, Clinical Operations
Peter leads global trial delivery across oncology and immunology portfolios.
Grace Adeyemi
Head of Patient Engagement
Grace designs the patient-experience programmes that shape trial recruitment and retention.
Dr. Yuki Tanaka
VP, Regulatory Affairs
Yuki leads global regulatory strategy for rare disease and plasma-derived therapies.
Dr. Omar Farouk
Global Head of Medical Affairs
Omar leads evidence generation and scientific engagement across respiratory.
Amara Nwosu
Head of Real-World Evidence
Amara builds the evidence base that supports access and reimbursement decisions.
Nadia Haddad
Chief Digital Officer
Nadia runs the digital and AI agenda spanning R&D, manufacturing and commercial.
Dr. Martin Kovac
Executive Director, Translational Medicine
Martin connects discovery science to first-in-human study design across virology.
Dr. Julien Marchand
VP, Biostatistics
Julien leads adaptive trial design and the statistical methods behind them.
Sarah Delacroix
Head of Manufacturing Technology
Sarah drives continuous manufacturing and digital-twin adoption across sterile sites.